TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Ferring Pharmaceuticals A/S
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,198,242
|
1,785,611
|
1,348,525 |
| Earnings before taxes |
130,061
|
90,517
|
69,821 |
| Total assets |
884,427
|
687,488
|
634,222 |
| Current assets |
495,546
|
305,068
|
304,051 |
| Current liabilities |
476,315
|
362,123
|
360,893 |
| Equity capital |
285,543
|
172,689
|
93,371 |
| - share capital |
754
|
708
|
671 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
32.3%
|
25.1%
|
14.7% |
| Turnover per employee |
6,281
|
5,102
|
3,853 |
| Profit as a percentage of turnover |
5.9%
|
5.1%
|
5.2% |
| Return on assets (ROA) | |||
| Current ratio |
104.0%
|
84.2%
|
84.2% |
| Return on equity (ROE) |
45.5%
|
52.4%
|
74.8% |
| Change turnover |
295,727
|
362,328
|
-61,695 |
| Change turnover % |
16%
|
25%
|
-4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.